“…Before reaching the atomic structure determination, amyloids can be characterized by several general structural features: the extent and location of residues involved in the amyloid core, the parallel or antiparallel, in-register or out-of-register arrangements of the β-strands in the axial direction and the straight, left-handed or right-handed twisted appearance. Protein assembly into amyloid fibrils can either be pathological such as Aβ and Tau in Alzheimer's, α-synuclein in Parkinson's, the prion protein PrP in Creutzfeldt-Jacob disease and the islet amyloid polypeptide (IAPP) in type 2 diabetes or functional [183], as has been shown for proteins involved in fungal heterokaryon incompatibility [184], mammalian skin pigmentation [185] and hormone storage [186], mammalian and fungal signaling pathways [9][10][11]187], bacterial cell-cell contacts, biofilms and cytoskeleton architecture [7,188,189]. Several prions and prion domains have also been identified as amyloid folds leading to characteristic phenotypes in yeast using ssNMR [53,54,56,[190][191][192].…”